Nuclear Medicine and Biology
Volume 36, Issue 5 , Pages 505-513, July 2009

Development of high-specific-activity 68Ga-labeled DOTA-rhenium-cyclized α-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors

  • Melchor V. Cantorias

      Affiliations

    • University of Missouri Research Reactor Center (MURR), Columbia, MO 65211, USA
    • ,
  • Said D. Figueroa

      Affiliations

    • Department of Radiology, University of Missouri, Columbia, MO 65212, USA
    • Harry S. Truman Memorial Veterans' Hospital, Columbia, MO 65201, USA
    • ,
  • Thomas P. Quinn

      Affiliations

    • Department of Biochemistry, University of Missouri, Columbia, MO 65211, USA
    • Harry S. Truman Memorial Veterans' Hospital, Columbia, MO 65201, USA
    • ,
  • John R. Lever

      Affiliations

    • Department of Radiology, University of Missouri, Columbia, MO 65212, USA
    • Harry S. Truman Memorial Veterans' Hospital, Columbia, MO 65201, USA
    • ,
  • Timothy J. Hoffman

      Affiliations

    • Department of Radiology, University of Missouri, Columbia, MO 65212, USA
    • ,
  • Lisa D. Watkinson

      Affiliations

    • Department of Radiology, University of Missouri, Columbia, MO 65212, USA
    • Harry S. Truman Memorial Veterans' Hospital, Columbia, MO 65201, USA
    • ,
  • Terry L. Carmack

      Affiliations

    • Department of Radiology, University of Missouri, Columbia, MO 65212, USA
    • Harry S. Truman Memorial Veterans' Hospital, Columbia, MO 65201, USA
    • ,
  • Cathy S. Cutler

      Affiliations

    • University of Missouri Research Reactor Center (MURR), Columbia, MO 65211, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 573 882 5211; fax: +1 573 882 6671.

Received 30 October 2008; received in revised form 26 January 2009; accepted 31 January 2009. published online 08 May 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(09)00043-2

doi:10.1016/j.nucmedbio.2009.01.017

Nuclear Medicine and Biology
Volume 36, Issue 5 , Pages 505-513, July 2009

Article Tools

* Image Usage & Resolution